Background Diabetes and elevated blood glucose have been associated with increased risk
of atrial fibrillation in a number of epidemiological studies, however, the findings have not …

Aims A network meta‐analysis (NMA) of all recommended drug groups for the treatment of
heart failure with reduced ejection fraction (HFrEF), including their combinations, was …

Appropriate interpretation of changes in markers of kidney function is essential during the
treatment of acute and chronic heart failure. Historically, kidney function was primarily …

Background Patients with acute myocardial infarction (MI) are at risk for developing heart
failure (HF) and subsequently are at an increased risk of mortality. Sodium-glucose …

Background Heart failure (HF) is frequent and its prevalence is increasing. We aimed to
evaluate the epidemiologic features of HF patients, the 1-year follow-up outcomes and the …

Objectives: This study compared the performance of major heart failure (HF) risk models in
predicting mortality and examined their utilization using data from a contemporary …

Heart failure (HF) is a major public health problem affecting more than 23 million patients
worldwide. Incidence and prevalence rates vary significantly according to the source of data …

Aims The prognosis of patients hospitalized for worsening heart failure (HF) is well
described, but not that of patients managed solely in non‐acute settings such as primary …

Aims Whether to continue or stop mineralocorticoid receptor antagonists (MRA) after an
episode of hyperkalaemia is a challenge in clinical practice. While stopping MRA may …

Background Patients hospitalized with heart failure (HF) with reduced ejection fraction have
high risk of rehospitalization or death. Despite guideline recommendations based on high …